PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
-3.65%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$342M
AUM Growth
+$342M
(-23%)
Cap. Flow
-$58.8M
Cap. Flow
% of AUM
-17.22%
Top 10 Holdings %
Top 10 Hldgs %
35.85%
Holding
99
New
15
Increased
34
Reduced
31
Closed
18
Top Buys
| 1 |
Tenet Healthcare
THC
|
$8.53M |
| 2 |
iRhythm Technologies
IRTC
|
$6.61M |
| 3 |
Neurocrine Biosciences
NBIX
|
$5.93M |
| 4 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$4.87M |
| 5 |
Teleflex
TFX
|
$4.44M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$13M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$10.9M |
| 3 |
DexCom
DXCM
|
$10.3M |
| 4 |
Avantor
AVTR
|
$8.43M |
| 5 |
Danaher
DHR
|
$6.42M |
Sector Composition
| 1 | Healthcare | 96.94% |
| 2 | Industrials | 2.69% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Idexx Laboratories
IDXX
$50.7B
| $5.14M | 1.5% |
9,388
-1,582
| -14% | -$865K |
|
|
APEN
27
DELISTED
Apollo Endosurgery, Inc.
APEN
| $4.9M | 1.43% |
810,411
-108,074
| -12% | -$654K |
|
|
SRRA
28
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $4.87M | 1.43% |
+151,915
| New | +$4.87M |
|
|
29
Teleflex
TFX
$5.57B
| $4.44M | 1.3% |
+12,500
| New | +$4.44M |
|
30
Legend Biotech
LEGN
$6.64B
| $4.38M | 1.28% |
+120,473
| New | +$4.38M |
|
31
Schrodinger
SDGR
$1.42B
| $3.95M | 1.16% |
115,891
+48,099
| +71% | +$1.64M |
|
32
Keros Therapeutics
KROS
$640M
| $3.95M | 1.16% |
72,690
+2,829
| +4% | +$154K |
|
33
Harvard Bioscience
HBIO
$21.1M
| $3.94M | 1.15% |
633,826
+96,745
| +18% | +$601K |
|
34
Fulcrum Therapeutics
FULC
$353M
| $3.89M | 1.14% |
164,453
-85,653
| -34% | -$2.03M |
|
35
Outset Medical
OM
$245M
| $3.71M | 1.08% |
81,601
+34,284
| +72% | +$1.56M |
|
36
Supernus Pharmaceuticals
SUPN
$2.52B
| $3.52M | 1.03% |
108,954
+4,240
| +4% | +$137K |
|
37
Insulet
PODD
$24.2B
| $3.38M | 0.99% |
12,671
-4,329
| -25% | -$1.15M |
|
38
908 Devices
MASS
$199M
| $3.33M | 0.97% |
+175,000
| New | +$3.33M |
|
39
ANI Pharmaceuticals
ANIP
$2.06B
| $3.03M | 0.89% |
107,911
-29,315
| -21% | -$824K |
|
|
PHLT
40
Performant Healthcare, Inc. Common Stock
PHLT
$602M
| $2.98M | 0.87% |
957,083
+107,083
| +13% | +$333K |
|
41
Charles River Laboratories
CRL
$7.99B
| $2.84M | 0.83% |
10,000
-15,901
| -61% | -$4.52M |
|
42
Maravai LifeSciences
MRVI
$341M
| $2.73M | 0.8% |
77,389
-21,299
| -22% | -$751K |
|
|
IMGO
43
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $2.69M | 0.79% |
139,751
+29,751
| +27% | +$573K |
|
|
BCYC
44
Bicycle Therapeutics
BCYC
$492M
| $2.51M | 0.74% |
57,295
-7,505
| -12% | -$329K |
|
45
MannKind Corp
MNKD
$1.69B
| $2.49M | 0.73% |
675,403
+409,548
| +154% | +$1.51M |
|
46
Health Catalyst
HCAT
$228M
| $2.08M | 0.61% |
79,746
+27,068
| +51% | +$707K |
|
47
Madrigal Pharmaceuticals
MDGL
$9.7B
| $1.99M | 0.58% |
20,230
-8,440
| -29% | -$828K |
|
48
KORU Medical Systems
KRMD
$187M
| $1.92M | 0.56% |
672,457
+74,847
| +13% | +$214K |
|
49
Altimmune
ALT
$325M
| $1.89M | 0.55% |
309,586
+46,112
| +18% | +$281K |
|
50
Gossamer Bio
GOSS
$587M
| $1.74M | 0.51% |
200,185
-346,236
| -63% | -$3.01M |
|